It wouldn’t be too much of a stretch to characterize Seattle’s Juno Therapeutics as the biotech company of the year for 2014. And depending on how the company progresses, by 2020, we might well be calling it the biotech of the decade.
The field of Cell Therapy is rapidly evolving. Exciting results from recently completed clinical trials show real promise for delivering help to very sick people needing new treatment options. To deliver these new therapies, industry is actively searching for innovative bioprocess manufacturing solutions. These solutions need to consistently provide high quality product while meeting cost targets that will drive adoption by the medical community and payors. The innovative application of available technologies and a structured development process can help achieve this.